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ttp://dx.doi.org/10.1016/j.ajpath.2014.10.026Premature delivery occurs in 12% of all births, and accounts for nearly half of long-term neurological
morbidity, and 60% to 80% of perinatal mortality. Despite advances in obstetrics and neonatology, the
rate of premature delivery has increased approximately 12% since 1990. The single most common cause
of spontaneous preterm birth is infection. Several lines of evidence have demonstrated the role of
endothelin-1 as both a constrictor of uterine myometrial smooth muscle and a proinﬂammatory
mediator. Endothelin-1 activates the phospholipase C pathway, leading to activation of protein kinase
C and, in turn, sphingosine kinase (SphK). The inhibition of SphK has been recently shown to control
the proinﬂammatory response associated with sepsis. We show herein, for the ﬁrst time, that SphK
inhibition prevents inﬂammation-associated preterm birth in a murine model. Rescue of pups from
premature abortion with an SphK inhibitor occurs by suppression of the proinﬂammatory cytokines
tumor necrosis factor a, Il-1b, and Il-6 and attenuation of polymorphonuclear inﬂammatory cells into
the placental labyrinth. Moreover, we postulate that inhibition of SphK leads to suppression of
endothelin-converting enzyme-1 expression, indicating the presence of an endothelin-converting
enzyme 1/endothelin 1eSphK positive feedback loop. This work introduces a novel approach for the
control of infection-triggered preterm labor, a condition for which there is no effective treatment.
(Am J Pathol 2015, 185: 862e869; http://dx.doi.org/10.1016/j.ajpath.2014.10.026)Supported by NIH grant 1 R01 NS069577 (S.E.R.).
Disclosures: A provisional patent (61/964,127) on the use of sphingosine
kinase inhibition for the treatment and prevention of obstetrical disorders
has been ﬁled by S.E.R. and C.R.A.Preterm birth (PTB), deﬁned as any birth before 37 complete
weeks of gestation, accounts for 11.1% of all deliveries
worldwide, but next to congenital anomalies, accounts for most
perinatal morbidity and mortality. The United States, with a
rate of PTB of 11.7%, ranks among the 10 countries that have
the highest rates of PTB.1 The single most common cause of
spontaneous PTB is infection.2 Intrauterine bacteria interact
with cell surface recognition molecules, such as Toll-like
receptor-2 (Tlr2) and Tlr4,3,4 leading to release of T helper
cell 1 cytokines, such as Il-1b and tumor necrosis factor a
(TNFa).5e7 This inﬂammatory response culminates in the ﬁnal
steps of the parturition cascade, consisting of decreased pros-
taglandin metabolism, functional progesterone withdrawal,
increased expression of proteases and contraction-associated
proteins, and increased uterine contractile activity.8e10stigative Pathology.
.We have previously shown that endothelin 1 (Edn1) is a key
player in lipopolysaccharide (LPS)einduced PTB in a murine
model.11e14 Speciﬁcally, we have previously reported that
endothelin-converting enzyme 1 (Ece1), the enzyme that syn-
thesizes Edn1, colocalizes with its substrate in the placenta15
and that the Ece1 inhibitor, phosphoramidon, decreases rates
of PTB in a murine model of infection-associated preterm
labor.11 Subsequently, we have also shown that Ece1 levels
are increased in a mouse model of PTB and that rates of
preterm delivery are decreased with endothelin-A receptor
Sphingosine Kinase and Preterm Birthantagonists.12e14 Finally, we have shown that virtually com-
plete control of PTB is achieved in this model by silencing Ece1
mRNA.13 LPS, a Gram-negative bacterial wall component that
activates Tlr4, stimulates the synthesis of Edn1 by monocytes
and endothelial cells in vitro and in vivo.16e18
The activation of the phospholipase C pathway by Edn1
leads to activation of protein kinase C (PKC), which acts
upstream of sphingosine kinase (SphK).19,20 SphK, in turn,
can activate Rho kinase, ultimately leading to contraction of
myometrial tissue. SphK is the only enzyme that catalyzes
the conversion of SphK to sphingosine-1-phosphate, which
behaves in an autocrine manner in myometrial tissues and,
in orchestration with SphK, PKC, and extracellular signale
regulated kinase, leads to the induction of cyclooxygenase-2
and to labor.21
Two human SphK isozymes, SphK1 and SphK2, have been
identiﬁed,22 both of which are inhibited by sphingosine kinase
inhibitor II (SKI II), the compound used in the work reported
herein. We show herein, for the ﬁrst time, that inhibition of
SphK and consequent suppression of the SphK1-dependent
inﬂammatory pathway prevents infection-triggered PTB.
Materials and Methods
Reagents
LPS (serotype 026:B6), polyethylene glycol 400 (PEG 400),
and antibodies against TNFa, Il-1b, and Il-6 were purchased
from Sigma-Aldrich (St. Louis, MO), Il-10 antibody from Ep-
itomics (Burlingame, CA), Ece1 antibody from US Biological
(Swampscott, MA), and glyceraldehyde-3-phosphate dehy-
drogenase antibody from Cell Signaling Technology (Danvers,
MA). Lysis, loading, running, and transfer buffers as well as
molecular weight standards and polyvinylidene diﬂuoride
(PVDF) membranes were purchased from Life Technologies
(Grand Island, NY); skim milk powder from EMD Chemicals
(Gibbstown, NJ); bicinchoninic assay reagents from VWR
Scientiﬁc (Bridgeport, NJ); ECL Plus Western blotting detec-
tion system from GE Healthcare (Buckinghamshire, UK);
bovine serum albumin from Fisher Scientiﬁc (Pittsburgh, PA);
anti-rabbit IgG, horseradish peroxidaseelinked whole antibody
fromGEHealthcare (Buckinghamshire, UK); autoradiographic
ﬁlm from Denville Scientiﬁc (Metuchen, NJ); stripping buffer
from Thermo Scientiﬁc (Rockford, IL); universal labeled
streptavidin-biotin2 system, horseradish peroxidase (LSAB2
System, HRP) from Dako (Carpinteria, CA); xylene from
Malinckrodt Chemical Inc. (Washington, DC); and hematox-
ylin from VWR Scientiﬁc. The SphK inhibitor, SKI II, was
purchased fromTocris Bioscience (Ellisville,MO). Histochoice
mounting media was purchased from Amresco Inc. (Solon,
OH). All other reagents were purchased from VWR Scientiﬁc.
Animals
All experimental protocols involving animals were approved by
theSt. John’sUniversityAnimalCare andUseCommittee of theThe American Journal of Pathology - ajp.amjpathol.orgCollege of Pharmacy and Health Sciences and conducted ac-
cording to the guidelines in the Guide for the Care and Use of
Laboratory Animals.23 C57BL/6 mice from Taconic Labora-
tories (Cranbury, NJ) were used for all in vivo experiments. An-
imals were housed in individually ventilated cages in an animal
facilitywith controlled conditions of temperature (23C 1C),
humidity (50%  10%), and 12:12-hour light/dark cycles.
Standard laboratory chow andwater were provided ad libitum.
In Vivo Studies
A total of 17 timed pregnant embryonic day (E) 15.5 mice,
weighing between 28 and 35 g, were used for in vivo studies.
The control group (nZ 7) was injected i.p. with 50 mg/kg
LPS (serotype 026:B6; Sigma-Aldrich) dissolved in 0.5
mL phosphate-buffered saline (PBS) at time (T) Z 0 and
50 mL PEG 400 at T Z 1 and 7 hours. The treatment
group (nZ 7) was also injected i.p. with the same dose of
LPS and then injected with 50 mg/kg SphK inhibitor (SKI
II) dissolved in PEG 400 at TZ 1 and 7 hours. The sham
group (nZ 3) was injected i.p. with 0.5 mL PBS at TZ 0
and 50 mL PEG 400 at TZ 1 and 7 hours. After injections
at TZ 7 hours, mice were continuously observed for time
of delivery and number of pups dropped. Mice that did not
deliver were observed until T Z 24 hours. All mice were
euthanized by carbon dioxide asphyxiation and necropsied to
conﬁrm pregnancy, and the number of pups retained in utero
was recorded. The retained placentas and uteri were harvested
and stored at 80C or in 10% neutral-buffered formalin at
room temperature.
High-Capacity Real-Time RT-PCR
On necropsy, placental tissue was immediately harvested,
incubated in RNAlater (Qiagen, Valencia, CA), and stored
at 80C until ready for use. RNA was isolated using the
Qiagen RNeasy Mini Kit (Qiagen), according to the man-
ufacturer’s instructions, and the A260/A280 ratio was
measured to determine nucleic acid purity. Only samples
with an A260/A280 ratio of 1.8 to 2.1 were used. Reverse
transcription of RNA to cDNA was then performed using
Applied Biosystems/Life Technologies high-capacity cDNA
reverse transcription kit. Aliquots of 1 mg of RNA were used
per reaction, and cDNA was stored at 4C until ready for use.
Equimolar amounts of RNA from 10 different placentas from
10 different mice were pooled. Quantitative RT-PCR was
performed on a Roche LightCycler480 (Roche Diagnostics
Corporation, Indianapolis, IN). Qiagen’s RT2 Proﬁling PCR
Array (Qiagen) for 84 different genes involved in mouse Toll-
like receptor signaling (including housekeeping genes) was
used, following the manufacturer’s instructions.
Gel Electrophoresis
Frozen placentas were allowed to thaw on ice. Tissues were
homogenized in 0.25 mL ice cold lysis buffer, using a Polytron863
Table 1 SKI II Prevents LPS-Induced PTB and Spontaneous
Abortion
Group
LPS
control
SKI II
treatment Sham
LPS (50 mg/kg) received Yes Yes No
No. of mice 7 7 3
No. of mice delivered 5 1* 0
Total no. of pups 47 50 20
No. of pups spontaneously aborted 21 2**** 0
*P < 0.05, ****P < 0.0001.
LPS, lipopolysaccharide; PTB, preterm birth; SKI II, sphingosine kinase
inhibitor II.
Vyas et alhomogenizer (VWR, Bridgeport, NJ). The samples were ho-
mogenized on ice for 2 minutes at 15-minute intervals. This
procedure was continued for 2 hours, and the ﬁnal homogenates
were centrifuged at 10,000  g for 10 minutes. Volumes of
supernatant containing 30 to 40 mg of protein based on bicin-
choninic assay, using bovine serum albumin as standard, were
diluted in NuPAGE LDS sample buffer (Life Technologies,
Norwalk, CT), and the samples were heated at 95C for 5 mi-
nutes. Bis-Tris gels were used for protein separation. Gel elec-
trophoresis was performed in an XCell SureLock Mini-Cell
apparatus (LifeTechnologies). Thegelswere allowed to run for
45 minutes with 3-(N-morpholino) propanesulfonic acid
running buffer at 125 mA and 200 V. Proteins were then
transferred to a PVDF membrane, using an XCell II Blot
Module (Life Technologies). Transfer was performed for 2
hours on ice at a 170-mA current and a constant voltage of 30
V with NuPAGE transfer buffer (Life Technologies).
Western Blot Analysis
PVDF membranes were washed with Tris-buffered saline
containing 0.1% Tween 20 (TBS-T; Sigma-Aldrich), pH 7.8,
for 5 minutes and then blocked with 5% skim milk powder
(EMD Chemicals) in TBS-T solution for 1 hour. The mem-
branes were analyzed for different proteins using their respec-
tive primary antibodies (ie, TNFa, Il-1b, Il-6, Il-10, and Ece1)
diluted in the blocker solution overnight at 4C. The PVDF
membranes were washed with TBS-T three times at intervals of
15minutes at room temperature. Theywere then incubatedwithFigure 1 Sphingosine kinase inhibitor, sphingosine kinase inhibitor II (SKI II)
15.5 mice from preterm birth (PTB). Mice induced with 50 mg/kg LPS i.p. were tre
observed for PTB for a period of 24 hours. A: SKI II signiﬁcantly reduces the pe
percentage of pups lost to spontaneous abortion over time. C: SKI II signiﬁcantly
Kaplan-Meier survival curves for pups in both groups. *P < 0.05, ****P < 0.000
864a 1:1000 dilution of secondary antibody, anti-rabbit IgG,
horseradish peroxidaseelinked whole antibody, in blocker so-
lution for 2 hours at room temperature. The membranes were
thenwashedwith TBS-T four times at intervals of 15minutes at
room temperature. They were then treated with ECL Plus
Western blotting detection system (VWR), and the chem-
iluminescence produced by the chemical reaction was detected
by exposure to an autoradiography ﬁlm. On development of the
ﬁlm, the membranes were washed with TBS-T and stored in
TBS-T at 4C. For reprobing, the membranes were treated with
stripping buffer for 5 minutes at room temperature. They were
then washed with TBS-T three times at 10-minute intervals at
room temperature and incubated with primary antie glyceral-
dehyde-3-phosphate dehydrogenase or antieb-actin antibody
as the gel loading control. The same procedure was repeated
as above. The protein content was quantiﬁed using ImageJ
software version 1.48 (NIH, Bethesda, MD). Band density
was normalized to housekeeping protein glyceraldehyde-3-
phosphate dehydrogenase or b-actin. Each placenta subjected to
Western blot analysis came from a different dam. Western blot
experiments were performed at least three times, using at least
three placentas for each data point each time.
Histopathological Studies
IHC Data
Formalin-ﬁxed, parafﬁn-embedded tissue sectionswereused for
immunohistochemistry (IHC). The sectionswere deparafﬁnized
by washing in xylene for 3 minutes. They were then rehydrated
by washing in 100% isopropyl alcohol (two changes), 95%
alcohol, 80% alcohol, 70% alcohol, and distilled water for 3
minutes each. The sections were incubated for 5 minutes with
peroxidase block (3% hydrogen peroxide in water) and washed
in distilled water for 3 minutes. Antigen retrieval of the sections
was performed using citrate buffer (8.2 mmol/L sodium citrate
and 1.8 mmol/L citric acid, pH 6.0, containing 0.01% Triton X-
100) at 95C to 98C for 20minutes. The slideswere allowed to
cool for 20 minutes and were then washed with PBS (Sigma-
Aldrich) for 3 minutes. The sections were blocked with 1%
bovine serum albumin in PBS for 1 hour in a humidiﬁed
chamber. The sectionswere againwashed in PBS for 2minutes., rescues lipopolysaccharide (LPS)-stimulated timed pregnant embryonic day
ated with 50 mg/kg SKI II or polyethylene glycol (PEG) 400. All mice were
rcentage of mice delivering over time. B: SKI II signiﬁcantly reduces the
increases the rate of survival of pups in LPS-treated mice, as seen from the
1.
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Figure 2 Lipopolysaccharide (LPS)-induced up-regulation of Toll-like
receptor 4 pathway genes in embryonic day (E) 15.5 mouse placenta.
High-capacity real-time RT-PCR was performed on RNA isolated from pla-
centas harvested from LPS-treated and normal control E15.5 mice. Equi-
molar amounts of RNA from 10 different placentas from 10 different mice
were pooled. The gene expression heat map indicates up-regulation in red
and down-regulation in green. The location of the 84 tested genes (plus
housekeeping genes and controls) in the array is displayed in Supplemental
Table S1. A complete list of genes represented on the array, with UniGene
(http://www.ncbi.nlm.nih.gov/unigene) and GenBank (http://www.ncbi.
nlm.nih.gov/genbank) identiﬁers, gene symbols, and descriptions of cor-
responding proteins is provided in Supplemental Table S2.
Sphingosine Kinase and Preterm BirthPrimary antibodies directed against TNFa, Il-1b, and Il-6,
diluted in 1% bovine serum albumin, were used for incubation
for 1 hour in the humidiﬁed chamber. The slideswerewashed in
fresh PBS for 3 minutes. A biotinylated link was applied to the
sections for 10minutes, and the slideswere thenwashed in fresh
PBS for 3 minutes. Streptavidinehorseradish peroxidase was
then applied to the sections for 10 minutes, and the slides were
again washed in fresh PBS for 3 minutes. The 3,30-dia-
minobenzidine substrateechromogen solution was applied to
the sections for 5 minutes, and the slides were washed with
distilledwater for 3minutes.The sectionswere then immersed in
hematoxylin for 2 minutes and immediately washed in distilledTable 2 Differential Expression of Tlr4 Pathway Genes in Placentas fr
Down-regulated No change Up-regulated
Elk1 Fadd Agfg1 H
Nfkb2 Il10 Btk H
Rela Il12a Casp8 H
Ly86 Ccl2 If
Mapk9 Cd14 If
Ripk2 Cd80 Ik
Tlr3 Cd86 Il
Tlr5 Cebpb Il
Ube2n Chuk Il
Clec4e Il
Csf2 Il
Csf3 Ir
Eif2ak2 Ir
LPS, lipopolysaccharide; Tlr4, Toll-like receptor 4.
The American Journal of Pathology - ajp.amjpathol.orgwater for 3 minutes. The slides were wiped and mounted with
Histochoice mounting media and coverslipped. The sections
were observed under a Nikon Eclipse 80i light microscope
(Nikon Inc.,Melville, NY), and imageswere takenwith aNikon
Digital Sight camera (Nikon Inc.). Image-Pro Premier 3,30-
diaminobenzidine analysis software version 9.0 (Media Cy-
bernetics Manufacturing, Warrendale, PA) was used for quan-
tiﬁcation of the results. At least three placentas from three
different damswere subjected to IHCanalysis for each condition
and each cytokine.
Histological Analysis
Placental tissues harvested during necropsy and previously
stored in 10% buffered formalin were parafﬁn embedded,
divided into sections (4mmthick),mounted on clear glass slides,
and stained with hematoxylin and eosin. Sections of the tissues
were observed using a Nikon Eclipse 80i light microscope by
three blinded observers (V.V., S.S., andS.M.) andgraded for the
extent of inﬂammatory cell inﬁltration. The slides were initially
scanned at 100 magniﬁcation to identify any areas of inﬂam-
mation. The threemost activeﬁelds on each slidewere then used
for analysis at 400 magniﬁcation. The number of poly-
morphonuclear neutrophils were counted in the three ﬁelds, and
the average value was recorded. On the basis of the average
number of neutrophils per400 ﬁeld recorded, the slides were
assigned grades as follows: 0, 0 to 5 cells; 1, 6 to 50 cells; 2, 51 to
100 cells; and 3,>100 cells. At least three placentas from three
different dams were subjected to histological analysis for each
condition and each cytokine. The observers were trained by a
practicing pathologist (S.E.R.) before grading began, and
concordance among the three observers was conﬁrmedwith test
slides. Imageswere capturedwith aNikonDigital Sight camera.
Statistical Analysis
For in vivo studies, the effect of SKI II on the percentage of
LPS-stimulated mice delivering and on the percentage of pups
rescued from spontaneous abortion was evaluated with the c2
and Fisher exact tests, respectively. Differences in rates of PTBom LPS-Induced Mice
mgb1 Irf1 Nfkbib Tlr1
ras1 Irf3 Nfkbil1 Tlr2
spala Lta Nfrkb2 Tlr4
nb1 Ly96 Nr2c2 Tlr6
ng Map2k3 Peli1 Tlr8
bkb Map2k4 Pglyrp1 Tlr9
1a Map3k1 Ppara Tnf
1b Map3k7 Ptgs2 Tnfaip3
2 Mapk8 Rel Tnfrsf1a
6 Mapk8ip3 Thk1 Tollip
6ra Muc13 Ticam Tradd
ak1 Nfkb1 Ticam2 Traf6
ak2 Nfkb1a Tirap Ube2v1
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Figure 3 Sphingosine kinase inhibitor, sphingosine kinase inhibitor II (SKI
II), suppresses expression of placental inﬂammatory cytokines and endothelin-
converting enzyme-1 (Ece1) in lipopolysaccharide (LPS)-stimulated timed
pregnant embryonic day 15.5 mice. Placental tissue lysates from sham, LPS-
induced, and LPS-treated mice rescued from preterm birth with SKI II were
subjected to gel electrophoresis and immunoblotting. Western blots were
probed with antibodies directed against tumor necrosis factor a (TNFa;) (A),
Il-1b (B), Il-6 (C), Il-10 (D), and Ece1 (E). Glyceraldehyde-3-phosphate de-
hydrogenase (GAPDH) and b-actin were used as loading controls. Western blot
experiments were performed at least three times, using at least three placentas
from three different dams for each data point each time. One representative
immunoblot is shown for each group for each protein. Splicing of immunoblot
bands is indicated by white lines. *P < 0.05, **P < 0.01.
Vyas et aland rates of pups delivered over time were evaluated with log-
rank (Mantel-Cox) or Gehan-Breslow-Wilcoxon test. The
U-test, along with analysis of variance and Tukey’s multiple-
comparison test, was used to evaluate differences in inﬂam-
matory inﬁltration in histological sections. Differences in
mean expression of cytokine proteins in immunoblots and in
IHC were determined using analysis of variance with Tukey’s
multiple-comparison test.
Results
Treatment with 50 mg/kg SKI II signiﬁcantly reduced the
number of mice delivering because of LPS-induced inﬂam-
mation. In the LPS control group, which received LPS
(TZ 0 hour) and PEG 400 (TZ 1 and 7 hours), ﬁve (71%)
of seven mice delivered (Table 1 and Figure 1A) by the end
of the 24-hour experimental period. With SKI II treatment
(T Z 1 and 7 hours) after LPS injection, on the other hand,
only one (14%) of seven mice delivered prematurely (Table 1
and Figure 1A) by the end of 24 hours, showing a statistically
signiﬁcant effect of SKI II on LPS-induced PTB (P < 0.05).
None of the three mice in the sham group delivered prema-
turely, as expected (Table 1 and Figure 1A).
In addition to decreasing the number of mice delivering
prematurely, SKI II treatment rescued a signiﬁcant number of
pups from being dropped prematurely and hence spontane-
ously aborted. In the LPS control group, 21 (44%) of 47 pups
were dropped (Table 1 and Figure 1B) within the 24-hour
experimental time. In the treatment group, on the other hand,
only 2 (4%) of 50 pupswere dropped prematurely in the 24-hour
time period (P< 0.0001) (Table 1 and Figure 1B). In the sham
group, none of the 20 pups were delivered prematurely, as ex-
pected (Table 1). Comparison of the twoKaplan-Meier survival
curves by log-rank test revealed a statistically signiﬁcant dif-
ference between the two groups (P < 0.0001) (Figure 1C). No
signiﬁcant changes in litter size or fetal growth and development
were observed throughout the study, and no macroscopic
congenital anomalies were noted in any of the 97 pups.
We performed real-time RT-PCR analysis of 84 Tlr4-
associated mouse placental genes from E15.5 mice induced
by LPS and found up-regulation of most of the genes in this
panel (Figure 2, Table 2, and Supplemental Tables S1 and S2).
Genes encoding TNFa, Il-1b, and Il-6, which have been shown
to be elevated in amniotic ﬂuid in the setting of PTB, were all
up-regulated by LPS. In the current work, TNFa, Il-1b, and Il-6
expression were all signiﬁcantly increased in placental lysates
from LPS-induced mice as compared to shams (P < 0.05).
Moreover, levels of all of these proteins were reduced in the
SKI IIetreated group when compared to the LPS control group
(P < 0.05) (Figure 3, AeC). Interestingly, Il-10, an anti-
inﬂammatory cytokine, was similarly suppressed by SKI II
(Figure 3D), perhaps because its anti-inﬂammatory regulatory
role is made less necessary as a result of SphK inhibition.
On the basis of the premise that SphK acts downstream of
Ece1/Edn1, one would not expect SKI II to affect Ece1
levels. However, we found that SKI II clearly decreased866levels of Ece1 (Figure 3E). The suppression of Ece1 levels
by SKI II introduces a novel concept to our understanding
of the Ece1/Edn1-PKC-SphK pathway.
IHC analysis was used to determine the localization of
cytokines in the placenta and to conﬁrm the results obtainedajp.amjpathol.org - The American Journal of Pathology
Figure 4 Sphingosine kinase inhibitor, sphin-
gosine kinase inhibitor II (SKI II), suppresses
cytokine immunoreactivity in the placental laby-
rinth in lipopolysaccharide (LPS)-stimulated em-
bryonic day 15.5 mice. Sections of the placenta
from sham, LPS-induced, and LPS-treated mice
rescued from preterm birth with SKI II were ﬁxed
in formalin and subjected to immunohistochem-
istry, using antibodies directed against tumor ne-
crosis factor a (TNFa;) (A), Il-1b (C), and Il-6 (E).
Image-Pro Premier version 9.0 3,30-dia-
minobenzidine analysis software was used to
quantify intensity of immunoreactivity (B, D, and
F). Arrows indicate immunostaining. At least three
placentas from three different dams were sub-
jected to immunohistochemical analysis for each
condition and each cytokine. Representative sec-
tions are shown. **P < 0.01, ***P < 0.005.
Original magniﬁcation, 400 (A, C, and E).
Sphingosine Kinase and Preterm Birthfrom Western blot analysis. Placental labyrinthine tissue
from mice treated with LPS showed a signiﬁcant increase in
Il-1b and Il-6 levels as compared to shams (P < 0.0001)
(Figure 4, CeF). Interestingly, no such increase was seen in
TNFa (Figure 4, A and B). SKI II, however, signiﬁcantly
reduced labyrinthine levels of TNFa (P < 0.0001), Il-1b
(P < 0.0001), and Il-6 (P < 0.01) (Figure 4).
Placental labyrinthine tissue harvested from sham, LPS-
induced, and LPS-treated plus SKI II rescued mice showed
signiﬁcant differences in inﬂammatory cell recruitment.
Figure 5A shows a representative section of placental labyrinth
from an LPS-induced mouse with a robust neutrophilic inﬁl-
trate when compared to placental labyrinthine tissue from sham
mice (P< 0.01). With treatment with SKI II, the inﬂammatory
cell inﬁltrate subsides signiﬁcantly (P < 0.05) (Figure 5).
Discussion
This work presents a novel approach to controlling infection-
triggered PTB, a clinical challenge accounting for a signiﬁ-
cant amount of perinatal morbidity and mortality in both theThe American Journal of Pathology - ajp.amjpathol.orgUnited States and around the globe. Previous studies per-
formed by us and others have implicated the Ece1/Edn1 axis
in PTB. Edn1 binds to endothelin-A receptors and causes
myometrial contraction by activating the phospholipase C
pathway.24 In fact, amniotic Edn1, which increases in the
setting of infection, is a more potent uterine myometrial
muscle constrictor than oxytocin.25,26 Our laboratory has
shown that infection-associated PTB can be controlled by
inhibition of Edn1 synthesis11; endothelin-A receptor
blockade was performed with both BQ-123, a commercially
available antagonist,13 and 1-3-6-trisubstituted-2-carboxy-
quinol-4-one, a novel antagonist synthesized by our
collaborator12,14; and Ece1 mRNA silencing.13 Moreover,
we have shown that Ece1 knockdown decreases levels of
matrix metalloproteinase-1 in mouse placenta and uterus.27
This ﬁnding is signiﬁcant because matrix metalloproteinase
levels are increased during amniotic infection, causing zinc-
dependent catalysis of the extracellular matrix, resulting in
cervical ripening, rupture of fetal membranes, and placental
detachment.28 Thus, numerous studies indicate that Edn1
plays a role during both term labor and infection-associated867
Figure 5 Sphingosine kinase inhibitor, sphingosine kinase inhibitor II (SKI
II), suppresses recruitment of inﬂammatory cells to the placental labyrinth in
lipopolysaccharide (LPS)-stimulated embryonic day 15.5 mice. A: Sections of
placenta from sham, LPS-induced, and LPS-treated mice rescued from preterm
birth with SKI II were ﬁxed in formalin and stained with hematoxylin and eosin.
Arrows indicate neutrophils. B: Magnitude of inﬂammatory response was
graded on a four-point scale by three blinded observers (V.V., S.S., and S.M.). At
least three placentas from three different dams were subjected to histological
analysis for each condition and each cytokine. Representative sections are
shown. *P < 0.05, **P < 0.01. Original magniﬁcation, 400 (A).
Figure 6 Sphingosine kinase (SphK)eendothelin-converting enzyme 1
(Ece1) positive feedback loop. Synthesis of endothelin 1 (Edn1) triggers
activation of phospholipase C (PLC), which leads to activation of protein
kinase C (PKC) and SphK. Inhibition of SphK with sphingosine kinase
inhibitor II suppresses not only several inﬂammatory cytokines, but also
decreases levels of Ece1, which is known to act upstream of SphK. The data
support the existence of a positive feedback loop between SphK and the
Ece1/Edn1 axis. DAG, diacylglycerol; ET-1, endothelin 1; InsP3, inositol
triphosphate; PIP2, phospholipid phosphatidyl inositol 4,5-bisphophate;
S1P, sphingosine-1-phosphate.
Vyas et alpreterm labor, suggesting that it could serve as a pharma-
cotherapeutic target for the prevention of PTB. However,
knockout of Ece1 and Edn1, the genes encoding Ece1 and
Edn1, respectively, early in gestation results in craniofacial
and cardiac abnormalities, revealing the importance of Edn1
for normal embryonic development.29,30 Because Edn1
activates SphK via PKC,19 it was of interest to test whether
inhibition of SphK, a downstream mediator in the same
molecular pathway as Edn1, would offer a novel approach
to controlling PTB without producing teratogenic effects.
The importance of Tlr4 in infection-associated PTB has
been established; mice with a mutant form of Tlr4 are less
likely to deliver prematurely after LPS induction.3 Genomic
studies in our laboratory show concordance with the proﬁle of
cytokine expression seen in the quantitative RT-PCR per-
formed herein31 (Gene Expression Omnibus; http://www.ncbi.
nlm.nih.gov/geo; Accession number GSE49895), pointing to
TNFa, Il-1b, and Il-6 as important signaling molecules in the
LPS-induced inﬂammatory cascade. Il-6, in particular, is
implicated in the pathogenesis of the fetal inﬂammatory syn-
drome, a constellation of abnormalities resulting from in utero
exposure to inﬂammation, including periventricular leuko-
malacia and bronchopulmonary dysplasia.32
The data presented herein suggest that SphK inhibition may
prevent PTB triggered by Gram-negative bacterial infection by
suppressing several Tlr4-linked proinﬂammatory cytokines.
Although we used a relatively small number of mice in our
control and treated groups (n Z 7 each), the effect of SphK
inhibition is so dramatic that our study was adequately868powered. The effect of SKI II on dams at risk for PTB, and
particularly on pups at risk for spontaneous abortion, was
signiﬁcant (P < 0.05 and P < 0.001, respectively).
Although we chose a well-established model of
inﬂammation-associated PTB for this focused work,
inducing PTB with LPS does not represent all types of
infection-triggered PTB. Future lines of investigation include
repeating this work using peptidoglycan-polysaccharide to
simulate infection with Gram-positive bacteria and pol-
yinosinic:polycytidylic acid to simulate infection with
viral pathogens. Moreover, the effect of SphK inhibition
on PTB triggered by actual microorganisms, such as the
human periodontal pathogens Campylobacter rectus and
Porphyromonas gingivalis, should be tested before the
therapeutic potential of SphK inhibitors for PTB can
be evaluated.
SphK and sphingosine-1-phosphate participate in myo-
metrial contractions in the rat19; inhibition of SphK causes a
reduction in Edn1-mediated myometrial contraction. On the
basis of our ﬁnding of decreased placental Ece1 in LPS-
stimulated mice treated with SKI II as compared to LPS-
exposed mice that were not treated, we postulate that the
Ece1/Edn1-PKC-SphK pathway is regulated by positive
feedback with increasing activity of SphK in the setting of
infection, leading to more Edn1 synthesis and greater SphK
activity (Figure 6). Cyclooxygenase-2 levels correlate with
SphK levels in late gestation.21 This is the ﬁrst report, to our
knowledge, however, showing that inhibition of SphK con-
trols PTB or any other in vivo model of LPS-triggered
inﬂammation-based disorder via suppression of cytokine
and inﬂammatory cell inﬁltration.ajp.amjpathol.org - The American Journal of Pathology
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